Crossref
What we know from Lp(a)HORIZON and what remains unknown
Progress in Cardiovascular Diseases · 2026-11
DOI: 10.1016/j.pcad.2026.11.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Progress in Cardiovascular Diseases, 2026-11. Verfasst von Ahmed Abdelaziz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Al-Azhar University, Cairo, Egypt. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Cardiovascular risk factorsClinical trialsLp(a) loweringPelacarsen
Autor:innen und Institutionen
- Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
- Division of Cardiology, Montefiore Health System, Albert Einstein College of Medicine, New York, NY, USA.
- Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: DLBhattMD@post.Harvard.edu.
Zitieren
APA
Abdelaziz, A., Slipczuk, L., & Bhatt, D. L. (2026). What we know from Lp(a)HORIZON and what remains unknown. Progress in Cardiovascular Diseases. https://doi.org/10.1016/j.pcad.2026.11.005
Vancouver
Abdelaziz A, Slipczuk L, Bhatt DL. What we know from Lp(a)HORIZON and what remains unknown. Progress in Cardiovascular Diseases. 2026. doi:10.1016/j.pcad.2026.11.005
BibTeX
@article{Abdelaziz2026,
author = {Abdelaziz, Ahmed and Slipczuk, Leandro and Bhatt, Deepak L},
title = {What we know from Lp(a)HORIZON and what remains unknown},
journal = {Progress in Cardiovascular Diseases},
year = {2026},
doi = {10.1016/j.pcad.2026.11.005}
}
EUVIMED